| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115
The proapoptotic function of c-Abl is in part mediated by its functional interaction with p73, a p53 homologue. Although it has been shown that c-Abl-mediated p73 activation in response to genotoxic stress is associated with an increase of p73 protein levels, the underlying mechanism remains unclear. We show here that c-Abl increases the cellular p73 abundance through a mode of posttranslational regulation. Analogous to its functional activation of p73, the kinase activity is essential for c-Abl to up-regulate p73 protein levels. Analysis of phosphorylation-resistant mutants of p73 reveals that the effect of c-Abl is mediated by its direct phosphorylation on the p73 protein. Consequence to the phosphorylation is a marked increase of the association between c-Abl and p73 via the binding of tyrosine-phosphorylated p73 to the c-Abl Src homology 2 (SH2) domain. Of functional importance of this phosphorylation-induced interaction in p73 stabilization is the demonstration that expression of a c-Abl SH2 domain peptide, which impedes phosphorylation-dependent association, results in an almost complete abrogation of c-Abl-dependent p73 accumulation. Importantly, expression of the c-Abl SH2 domain peptide also leads to an efficient inhibition of cisplatin-induced accumulation of endogenous p73, highlighting the biological significance. In keeping with its retained phosphorylation sites, the NH2-terminal truncated (
N) isoforms of p73, which are antiapoptotic, are also phosphorylated and stabilized by c-Abl, suggesting a possibility that c-Abl contributes to either pro- or antiapoptotic process depending on the expression profile of p73 isoforms.
This article has been cited by other articles:
|
|
 |
|
  D. Levy, N. Reuven, and Y. Shaul A Regulatory Circuit Controlling Itch-mediated p73 Degradation by Runx J. Biol. Chem., October 10, 2008; 283(41): 27462 - 27468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Alvarez, A. Klein, J. Castro, G. I. Cancino, J. Amigo, M. Mosqueira, L. M. Vargas, L. F. Yevenes, F. C. Bronfman, and S. Zanlungo Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease FASEB J, October 1, 2008; 22(10): 3617 - 3627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. I. Cancino, E. M. Toledo, N. R. Leal, D. E. Hernandez, L. F. Yevenes, N. C. Inestrosa, and A. R. Alvarez STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's {beta}-amyloid deposits Brain, September 1, 2008; 131(9): 2425 - 2442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Li, J. C. Morales, A. Hwang, M. W. Wagner, and D. A. Boothman DNA Mismatch Repair-dependent Activation of c-Abl/p73{alpha}/GADD45{alpha}-mediated Apoptosis J. Biol. Chem., August 1, 2008; 283(31): 21394 - 21403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang and X. Chen {Delta}Np73 Modulates Nerve Growth Factor-Mediated Neuronal Differentiation through Repression of TrkA Mol. Cell. Biol., May 15, 2007; 27(10): 3868 - 3880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Dicker, A. P. Kater, C. E. Prada, T. Fukuda, J. E. Castro, G. Sun, J. Y. Wang, and T. J. Kipps CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53 Blood, November 15, 2006; 108(10): 3450 - 3457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. O'Brien and R. Brown Signalling cell cycle arrest and cell death through the MMR System Carcinogenesis, April 1, 2006; 27(4): 682 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Dulloo and K. Sabapathy Transactivation-dependent and -independent Regulation of p73 Stability J. Biol. Chem., August 5, 2005; 280(31): 28203 - 28214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Urist, T. Tanaka, M. V. Poyurovsky, and C. Prives p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2 Genes & Dev., December 15, 2004; 18(24): 3041 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Toh, M. M. Siddique, L. Boominathan, K. W. Lin, and K. Sabapathy c-Jun Regulates the Stability and Activity of the p53 Homologue, p73 J. Biol. Chem., October 22, 2004; 279(43): 44713 - 44722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Waxman and P. S. Schwartz Harnessing Apoptosis for Improved Anticancer Gene Therapy Cancer Res., December 15, 2003; 63(24): 8563 - 8572. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
